AC

Anju Chatterji

Chief Technical Officer

HilleVax

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
HilleVax
Industry
research
Employees
36.0
Seniority
C suite
Annual Revenue
1000000.0

Technologies

Outlook Microsoft Office 365 Pantheon Jobvite Bootstrap Framework Google Tag Manager Mobile Friendly Varnish WordPress.org Google Analytics Nginx

Keywords

biotechnology: biological products (no diagnostic substances) health care biotechnology research biopharmaceutical novel vaccines norovirus vaccine hil-214 vaccine development clinical trials acute gastroenteritis virus-like particle immunogenicity public health global health clinical proof of concept prevention of illness phase 1 trials phase 2 trials adjuvants vaccine commercialization safety profile vaccine efficacy health disparities vaccine candidates target populations vaccine pipeline research & development biotechnology healthcare innovations clinical study infectious diseases immunization clinical data patient safety global vaccine access health economics gastroenteritis treatment epidemic outbreaks regulatory approval market launch vaccine technology infectious disease prevention vaccine manufacturing biologics development clinical operations societal costs of disease financial health strategies stakeholder engagement partnerships in healthcare biopharmaceutical market investor relations healthcare workforce health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans